KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Other Non-Current Liabilities (2016 - 2025)

Charles River Laboratories International has reported Other Non-Current Liabilities over the past 17 years, most recently at $138.3 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 29.15% year-over-year to $138.3 million; the TTM value through Dec 2025 reached $138.3 million, down 29.15%, while the annual FY2025 figure was $138.3 million, 29.15% down from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $138.3 million at Charles River Laboratories International, down from $189.5 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $242.9 million in Q4 2021 and troughed at $138.3 million in Q4 2025.
  • A 5-year average of $201.8 million and a median of $195.8 million in 2024 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 37.19% in 2024 and later dropped 29.15% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $242.9 million in 2021, then dropped by 28.02% to $174.8 million in 2022, then rose by 27.67% to $223.2 million in 2023, then dropped by 12.54% to $195.2 million in 2024, then decreased by 29.15% to $138.3 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CRL at $138.3 million in Q4 2025, $189.5 million in Q3 2025, and $185.2 million in Q2 2025.